1,012
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Design of Two Liquid Ibuprofen-Poloxamer-Limonene or Menthol Preparations for Dermal Administration

&
Pages 287-293 | Received 10 Aug 2006, Accepted 04 Sep 2006, Published online: 10 Oct 2008

Figures & data

TABLE 1 Formulation composition of poloxamer gels and solutions

FIG. 1 Sol-gel transition temperature for 30% P- 407, containing 5% Na.ibuprofen and either 2% of d-limonene or 2% of 1-menthol. (Means ± SE, n = 5).

FIG. 1 Sol-gel transition temperature for 30% P- 407, containing 5% Na.ibuprofen and either 2% of d-limonene or 2% of 1-menthol. (Means ± SE, n = 5).

FIG. 2 Viscosity complex (η*) values as modified by temperature, expressed as mPas/s of 30% p-407 plus 20% ibuprofen containing either 2% of d-limonene or 2% of 1-menthol in ibuprofen fluid preparations.

FIG. 2 Viscosity complex (η*) values as modified by temperature, expressed as mPas/s of 30% p-407 plus 20% ibuprofen containing either 2% of d-limonene or 2% of 1-menthol in ibuprofen fluid preparations.

TABLE 2 Terpene effect on percutaneous permeation of ibuprofen from gel and fluid preparations

FIG. 3 Permeation pattern for ibuprofen from 30% P-407 fluid preparations using 1-menthol or d-limonene as enhancers. (Means ± SD, n = 5.)

FIG. 3 Permeation pattern for ibuprofen from 30% P-407 fluid preparations using 1-menthol or d-limonene as enhancers. (Means ± SD, n = 5.)

FIG. 4 Permeation pattern for ibuprofen from 30% P-407 gels using 1-menthol or d-limonene as enhancers. (Means ± SD, n = 5.)

FIG. 4 Permeation pattern for ibuprofen from 30% P-407 gels using 1-menthol or d-limonene as enhancers. (Means ± SD, n = 5.)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.